Avant Diagnostics Inc (AVDX)

Not featured in screeners

Not featured in screeners

Ticker: AVDX Exchange: PNK

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings

Top insiders

Company data & Insiders

Download results Settings

INFUSION 51A, L.P.

1 sale — total 16,800 USD

Sale 23 Aug 2017

Value US$2,628,333.71 | Price 266.97 | Shares 4,937

INFUSION 51A, L.P.

1 sale — total 16,800 USD

Sale 9 Aug 2017

Value US$2,226,130.89 | Price 306.70 | Shares 2,184

VOLLMERS ALVARO

See Remarks

1 purchase — total 155 USD

Buy 4 May 2010

Value US$155.00 | Price 0.00 | Shares 1,550,000

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other

Notification date	Transaction date	B/S Transaction type	Insider and/or position	Nb. shares Price Value	Number of shares	Price	Value
2017-09-26	2017-08-23	S Sale	INFUSION 51A, L.P. Large shareholder	4,937 +46.6% 266.97 US$2,628,334	4,937 +46.6%	266.97	US$2,628,334
2017-09-26	2017-08-09	S Sale	INFUSION 51A, L.P. Large shareholder	2,184 -36.0% 306.70 US$2,226,131	2,184 -36.0%	306.70	US$2,226,131
2010-05-10	2010-05-04	B Purchase	VOLLMERS ALVARO See Remarks Executive Director Large shareholder	45,950 +27.2% 489.70 US$4,846,114	45,950 +27.2%	489.70	US$4,846,114

More insider trading research around Avant Diagnostics Inc